BioSpace News Archive

The NDA submission is based on a comprehensive clinical efficacy and safety package with data from more than 30 clinical trials and more than 1,500 patients with MDD.

The conference is organised by the Cholangiocarcinoma Foundation and will be held from 31 January to 2 February 2018.

A study in AACC’s The Journal of Applied Laboratory Medicine has for the first time established female-specific reference ranges for several biological variables that play key roles in thrombosis--or blood clotting--during pregnancy.

[31-January-2018] MADISON, Wis., Jan. 31, 2018 /PRNewswire/ -- Terso Solutions, Inc ., a leading technology company delivering automated supply chain solutions, announced the official opening of their new US production facility based near their headquarters in Madison, Wisconsin. The move from the current 6,000 square foot facility to a 30,000 square foot production facility considerably

All of the shares to be sold in the offering will be offered by OncoSec.

The dismissal relates to an action brought on November 8, 2016 by a purported shareholder of the Company against the Company and two individual defendants.

BioStrata announced senior promotions to two new leadership roles at the company. Helen Stewart-Miller takes up the newly formed Director of PR Services role, while Craig Townsend will become BioStrata’s first Director of Sales and Marketing Services.